Vetbiolix publishes new clinical results

Vetbiolix announces the publication of the results of its proof-of-concept clinical study on the VBX-1000 molecule, developed for the treatment of canine periodontitis.

This publication in the scientific journal Frontiers in Veterinary Science marks an important milestone in the advancement of the company’s clinical development programme in animal health.

This publication also confirms the momentum of research into VBX-1000 and reinforces the prospects for the ongoing clinical programme.